341 related articles for article (PubMed ID: 25252902)
1. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Siekmeier R; Hofmann T; Scheuch G
Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
[TBL] [Abstract][Full Text] [Related]
2. Role of long term antibiotics in chronic respiratory diseases.
Suresh Babu K; Kastelik J; Morjaria JB
Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
4. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Shteinberg M; Schneer S; Lavon O; Adir Y
Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
[TBL] [Abstract][Full Text] [Related]
5. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
Zuckerman JM
Infect Dis Clin North Am; 2004 Sep; 18(3):621-49, xi-. PubMed ID: 15308279
[TBL] [Abstract][Full Text] [Related]
6. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
[TBL] [Abstract][Full Text] [Related]
8. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
Haworth CS; Bilton D; Elborn JS
Respir Med; 2014 Oct; 108(10):1397-408. PubMed ID: 25301290
[TBL] [Abstract][Full Text] [Related]
9. Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
Zuckerman JM; Qamar F; Bono BR
Infect Dis Clin North Am; 2009 Dec; 23(4):997-1026, ix-x. PubMed ID: 19909895
[TBL] [Abstract][Full Text] [Related]
10. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Shimizu T; Suzaki H
Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
[TBL] [Abstract][Full Text] [Related]
11. Macrolides in cystic fibrosis.
McArdle JR; Talwalkar JS
Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for lower respiratory tract infections.
Liapikou A; Torres A
Expert Opin Pharmacother; 2014 Nov; 15(16):2307-18. PubMed ID: 25216725
[TBL] [Abstract][Full Text] [Related]
13. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
[TBL] [Abstract][Full Text] [Related]
16. The evidence base for non-CF bronchiectasis is finally evolving.
Serisier DJ
Respirology; 2014 Apr; 19(3):295-7. PubMed ID: 24620757
[No Abstract] [Full Text] [Related]
17. Inhaled antimicrobial therapy - barriers to effective treatment.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
[TBL] [Abstract][Full Text] [Related]
18. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
Eraković Haber V; Bosnar M; Kragol G
Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
[TBL] [Abstract][Full Text] [Related]
19. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
20. Role of macrolide therapy in chronic obstructive pulmonary disease.
Martinez FJ; Curtis JL; Albert R
Int J Chron Obstruct Pulmon Dis; 2008; 3(3):331-50. PubMed ID: 18990961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
